Gastroduodenal safety and tolerability of lumiracoxib compared with Ibuprofen and celecoxib in patients with osteoarthritis

MLA

Christopher C, Hawkey, et al. “Gastroduodenal Safety and Tolerability of Lumiracoxib Compared with Ibuprofen and Celecoxib in Patients with Osteoarthritis.” The Journal of Rheumatology, vol. 31, no. 9, Sept. 2004. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........22c3a1756e49ff46904d8c1560afa80e&authtype=sso&custid=ns315887.

APA

Christopher C, H., Petr, S., Irena F, F.-F., Evgeny L, N., Eduard G, P., Marc, C., Xavier, G., & Godehard, H. (2004). Gastroduodenal safety and tolerability of lumiracoxib compared with Ibuprofen and celecoxib in patients with osteoarthritis. The Journal of Rheumatology, 31(9).

Chicago

Christopher C, Hawkey, Svoboda Petr, Fiedorowicz-Fabrycy Irena F, Nasonov Evgeny L, Pikhlak Eduard G, Cousin Marc, Gitton Xavier, and Hoexter Godehard. 2004. “Gastroduodenal Safety and Tolerability of Lumiracoxib Compared with Ibuprofen and Celecoxib in Patients with Osteoarthritis.” The Journal of Rheumatology 31 (9). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........22c3a1756e49ff46904d8c1560afa80e&authtype=sso&custid=ns315887.